Loading clinical trials...

Next Generation Cataract and Vitreoretinal Surgery Study | Clinical Trials | Clareo Health

COMPLETEDNANCT06165744

Next Generation Cataract and Vitreoretinal Surgery Study

The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect formal user feedback.

Lead sponsor: Alcon Research•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment120

Start dateFeb 2024

Last updatedJun 25, 2025

Condition

Vitreoretinal Disease With or Without Cataracts

Locations shown

NSW Retina Pty Ltd

Hurstville, New South Wales

Southwest Retina

Liverpool, New South Wales

Sydney Retina Clinic & Day Surgery

Sydney, New South Wales

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 25, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions